A c-Jun N-terminal kinase inhibitor, JNK-IN-8, sensitizes triple negative breast cancer cells to lapatinib
Nancy D. Ebelt(City of Hope), Carla L. Van Den Berg(The University of Texas at Austin)
Cited by 40
Related Papers
Jnk2 Effects on Tumor Development, Genetic Instability and Replicative Stress in an Oncogene-Driven Mouse Mammary Tumor Model
|PLoS ONE|2010|47
5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma
|Frontiers in Immunology|2020|28
Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Restructures the Immune Contexture to Improve Checkpoint Blockade Efficacy
|Biomedicines|2020|20
Restructuring of the Immune Contexture Improves Checkpoint Blockade Efficacy in Murine Lung Cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0
Transcription Factor EB (TFEB) activity increases resistance of TNBC stem cells to metabolic stress
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0